Skip to content

Author

Karen M. Mustian

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Immune checkpoint inhibitor–related endocrinopathies: Real-world assessment strategies and best practices.

Thyroid dysfunction was the most consistently documented endocrinopathy, while adrenal insufficiency and hypopituitarism showed more variability in documentation and CTCAE grade assignment, which varied across participating sites.

Hala Awad, M. Mohamed, Alfredo V. Chua et al. · 0 citations
Open access Sep 2026

Sarcopenia Is Associated With Severe Treatment Toxicity and Mortality in Older Adults With Advanced Cancer: A Secondary Analysis

ABSTRACT Background Sarcopenia, a loss of muscle strength, quantity and performance that occurs primarily from ageing or secondary to disease, is hypothesized to worsen treatment outcomes in patients with cancer. Most published studies, however, focus solely on muscle quantity in patients under 70. Here, we evaluate th...

Lindsey J. Mattick, Mostafa Mohammed, Chin-Shang Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.